HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity

Trivedi Global, Inc. Announces Research by Alice Branton on Trivedi Effect® Energy Treated Lead Las Vegas, Nevada, USA, June 05, 2019 (GLOBE NEWSWIRE) -- Alice Branton, today released research results on the impact of biofield energy treatment on the physicochemical properties of lead. The...

Hygenall Introduces Hand Wipes to Reduce Risk of Lead Exposure Commonly Found on Children's Toys and Household Items NEWINGTON, NH--(Marketwire - February 10, 2009) - Hygenall Safety Products, a division of Mk-IX Technologies Corporation, today announced the availability of Hygenall™ hand wipes. Leveraging a...